Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
In 2018, life sciences companies were, once again, popular targets of securities class action lawsuits. Prudent life sciences companies should continue to take heed of the results of the decisions and filings in 2018 to ensure that they are aware of the recent developments in the law as well as filing trends. Last year, plaintiffs filed a total of 86 class action securities lawsuits against life sciences companies.
The primary goal of this review is to expand our understanding of the claims made about the effectiveness of the FC in medical education by reviewing the current body of research. We sought to answer three research questions: (i) What is the scope of the studies that have been published on FCs in medical education? (ii) What is the research quality of the studies examined? (iii) What are the effects of the FC, as reported by controlled studies?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
